mGem: Opening Env and harnessing NK cell effector functions to eliminate HIV-1-infected cells. [PDF]
Richard J, Finzi A.
europepmc +1 more source
Non-integrase mechanisms for dolutegravir resistance. [PDF]
Engelman AN.
europepmc +1 more source
Structure and Dynamics of the HIV-1 Envelope Protein on the Virion Envelope. [PDF]
Majumder A, Dutta M, Cherek L, Voth GA.
europepmc +1 more source
Bioorthogonal click-chemistry labeling and visualization of dual noncanonical amino acid-incorporated HIV-1 Env on intact virions. [PDF]
Gonepudi NK, Xu W, Awuah HB, Lu M.
europepmc +1 more source
Virus particle-based antibody-dependent cellular phagocytosis assay for HIV. [PDF]
Upadhyay C, Rao PG.
europepmc +1 more source
Oncogenic role of ERV with therapeutic potential. [PDF]
Xia PH, Zhao WL, Xiong J.
europepmc +1 more source
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex. [PDF]
Guenaga J +25 more
europepmc +1 more source
Near-full-length genomic characterization and phylogenetic analysis of an HIV-1 CRF02_AG/G second-generation recombinant in Ningxia, China. [PDF]
Mutalifu S +7 more
europepmc +1 more source
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development. [PDF]
Habib R +50 more
europepmc +1 more source
Phylogenetic Evidence of Local HIV-1 Transmission and Antiretroviral Drug Resistance in the Middle East and North Africa. [PDF]
Al-Fraihat E +7 more
europepmc +1 more source

